Close Menu

Lung Cancer

News and reporting on lung cancer.

The firm reported no revenues, but it managed to cut its net loss as it prepares to launch its LungExpress Dx product in the US later this year.

The companies — Rosetta Genomics, MDRNA, and Tekmira Pharmaceuticals — have all seen their shares more than double since Dec. 31, significantly outperforming the Nasdaq Biotechnology Index.

A separate deal under which Prometheus agreed to acquire 2 million shares of Rosetta at $4 per share has also been completed.

NCI Director John Niederhuber said last week that the institute plans to expand the Cancer Genome Atlas project to 20 to 25 major tumor types, and to apply next-generation sequencing to at least 100 tumor samples for each of several types of childhood cancers under the TARGET initiative.

In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

Based on the results of the study, the company has assembled a panel of six protein biomarkers with the ability to detect non-small cell lung cancer in patients with 94 percent sensitivity and 93 percent specificity. The company is hoping to launch the test by 2012.

Attendees heard about the past and future of the Cancer Genome Atlas at the American Association for Cancer Research meeting in Denver this week, as the pilot stage of the project nears completion.

In doing so, Rosetta is meeting its objective of finding commercialization partners for its existing products as it shifts its focus onto tests that screen for, rather than diagnose, disease.

Personalized medicine

MDRNA also reported its fourth-quarter financial results, posting lower operating costs on the elimination of non-RNAi programs and operations the company was working on prior to a corporate reorganization.

Pages

President Donald Trump announced the US would be leaving the World Health Organization, NBC News reports.

A study of Great Danes homes in on a genomic region linked to fearfulness.

CDC head says a new analysis indicates earlier testing wouldn't have caught viral spread, NPR reports.

In PLOS this week: gene expression and epigenetics of Indonesian populations, hookworm parasite secretome, and more.